PSMA and C-11 Choline PET in Patients With Biochemical Recurrence of Prostate Cancer
Status:
Active, not recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
Imaging and staging of prostate cancer is critical for surgical and treatment planning. In
this protocol we will image patients with suspected metastatic prostate cancer using
11C-Choline PET and Gallium-68 labeled HBED-CC PSMA (more commonly called 68Ga-PSMA-11) or
F-18 labeled PSMA 1007 in order to demonstrate their utility in detecting prostate cancer.